Sort
59,101 grants matching “hypertension”
Improving the Collaborative Health of Minority COVID-19 Survivor & Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities
$648,398Gayenell Smith Magwood · University Of South Carolina At Columbia · R01 · FY2024 · NR
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse
$648,371S. Michael Owens · Univ Of Arkansas For Med Scis · R01 · FY2016 · DA
Longitudinal Study of Risk Factors for Mesoamerican Nephropathy among Agricultural Workers in El Salvador, Central America
$648,292Madeleine Scammell · Boston University Medical Campus · R01 · FY2020 · ES
Hypertension Improvement Project (HIP)
$648,242Laura P Svetkey · Duke University · R01 · FY2007 · HL
Global Omics and Viromics Initiative on Pregnancy
$648,169Gregory A Buck · Virginia Commonwealth University · R01 · FY2019 · HD
Global Omics and Viromics Initiative on Pregnancy
$648,169Gregory A Buck · Virginia Commonwealth University · R01 · FY2020 · HD
Maternal Marijuana Use During Pregnancy, Marijuana Legalization, and Adverse Obstetrical and Neonatal Outcomes: A 12-year Cohort Study
$648,158Kelly Corinne Young-Wolff · Kaiser Foundation Research Institute · R01 · FY2020 · DA
Maternal Heart Health Starts at Home (MomHeart): Targeting Place-Based Social Determinants to Improve Pregnancy and Postpartum Cardiovascular
$648,124Kartik Kailas Venkatesh · Ohio State University · R01 · FY2025 · HL
Role of GPR173 in the central control of plasma volume expansion in pregnancy
$648,102Gina L.c. Yosten · Saint Louis University · R01 · FY2025 · HD
Anti-Angiogenic Preeclamptic Milieu Impairs Infant Lung and Vascular Development
$648,090Robert S. Tepper · Indiana University Indianapolis · R01 · FY2016 · HL
Biventricular Pacing After Cardiopulmonary Bypass
$648,084Henry Michael Spotnitz · Columbia University Health Sciences · R01 · FY2010 · HL
The ADHINCRA Study: Addressing HypertensIoN Care in AfRicA
$648,073Yvonne Commodore-Mensah · Johns Hopkins University · R01 · FY2024 · HL
Adrenal Origins of Aldosterone Excess
$648,072William E Rainey · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Adrenal Origins of Aldosterone Excess
$648,072William E Rainey · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Adrenal Origins of Aldosterone Excess
$648,072William E Rainey · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
Pragmatic Trial of Technology-Supported Behavioral Obesity Treatment in the Primary Care Setting: A Multiphase Effectiveness and Implementation Hybrid Design
$648,035Rena R Wing · Miriam Hospital · R18 · FY2017 · DK
Pragmatic Trial of Technology-Supported Behavioral Obesity Treatment in the Primary Care Setting: A Multiphase Effectiveness and Implementation Hybrid Design
$648,035Rena R Wing · Miriam Hospital · R18 · FY2019 · DK
Pragmatic Trial of Technology-Supported Behavioral Obesity Treatment in the Primary Care Setting: A Multiphase Effectiveness and Implementation Hybrid Design
$648,035Rena R Wing · Miriam Hospital · R18 · FY2020 · DK
Cardiometabolic Risk Development and Management in Changing Neighborhoods: the Jackson Heart Study
$648,027Sharrelle M Barber · Drexel University · R01 · FY2023 · HL
Animal Models for Studying the Genetics of Hypertension
$647,991Oliver Smithies · Univ Of North Carolina Chapel Hill · R01 · FY2014 · HL
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
$647,971Theresa I. Shireman · Brown University · R01 · FY2024 · MH
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
$647,956Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · DK
Early Detection of Right Ventricular Dysfunction and Emerging Pulmonary Hypertension in Systemic Sclerosis
$647,833Monica Mukherjee · Johns Hopkins University · R01 · FY2025 · HL
Molecular Mechanism of RhoA-mediated Ca2+-sensitization in Vascular Smooth Muscle
$647,800Avril V. Somlyo · University Of Virginia · R01 · FY2015 · GM
Molecular Mechanism of RhoA-mediated Ca2+-sensitization in Vascular Smooth Muscle
$647,800Avril V. Somlyo · University Of Virginia · R01 · FY2014 · GM